BC intrinsic subtypes, including triple-negative breast cancer (TNBC) and Her2+, luminal A, and luminal B BCs, are characterized by immunohistochemistry (IHC) and have important differences in phenotype and prognosis2, 3. The gene discussed is ERBB2; the disease is breast cancer.